• Pages: 1-2
• First Published: 02 November 2012

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation^†‡

• Pages: 3-26
• First Published: 28 December 2012

• Pages: 27-35
• First Published: 12 December 2012

Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: A systematic review and meta-analysis^†‡

• Pages: 36-48
• First Published: 23 July 2012

Interleukin-28B polymorphism in hepatitis C and liver transplantation^†

• Pages: 49-58
• First Published: 24 September 2012

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death^†‡

• Pages: 59-68
• First Published: 11 September 2012

Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach^†

• Pages: 69-77
• First Published: 25 September 2012

• Pages: 78-88
• First Published: 18 October 2012

Impact of estimated liver volume and liver weight on gender disparity in liver transplantation^†‡§¶

• Pages: 89-95
• First Published: 24 September 2012

Center competition and outcomes following liver transplantation^†

• Pages: 96-104
• First Published: 19 October 2012

• Pages: 105-107
• First Published: 14 November 2012

Cytomegalovirus: Prophylaxis, preemption, or “Wait and Watch”^†‡

• Page: 108
• First Published: 29 October 2012

• Page: 109
• First Published: 02 December 2012

Twenty-four years after liver transplantation, the recipient becomes a body donor^†

• Pages: 110-112
• First Published: 19 October 2012

• Page: 113
• First Published: 28 December 2012